tirzepatide korea Eli Lilly's next-generation obesity treatment "retatrutide" has ignited competition for next-generat Tirzepatride

In addition, recent mediation analyses of EMPA-REG OUTCOME suggested that changes in markers of plasma volume were the most important mediators of the reduction in risk of cardiovascular death with empagliflozin vs placebo [5]

Lancet Oncol 19 (10): 1315-1327, 2018

doi:10.1089/thy.2016.0256 Nordio M, Pajalich R

2021 Jan 1;264 doi: 10.1016/j.lfs.2020.118668

If you are considering Mounjaro after gastric sleeve surgery but have not yet discussed this with your bariatric or diabetes team, request a specialist review to ensure the treatment is appropriate, safe, and aligned with your individual health needs and surgical history